Summary

About the company

Die Kernaktivität des Unternehmens NLS Pharmaceutics AG ist die Entwicklung und Vermarktung von Medikamenten zur Behandlung seltener und komplexer Erkrankungen des zentralen Nervensystems (CNS).

AI-generated

Knowledge

No knowledge articles yet

Once EvlaBio AG claims this profile, we will publish editorial articles and case studies together here.

Get started

Comparisons

EvlaBio AG in comparison

Soon

Industry comparisons are coming soon

We are preparing industry comparisons in which EvlaBio AG will be ranked by reviews, experience and specialisations.